The Min­istry of Health (MoH), via its Chem­istry, Food and Drugs Di­vi­sion ad­vis­es there is a vol­un­tary re­call of Pred­nisolone Ac­etate Oph­thalmic Sus­pen­sion USP I% w/v 5ml Eye Drops. The re­call was is­sued by the man­u­fac­tur­er, Ju­ven­cia Life­sciences Pri­vate Lim­it­ed due to pos­si­ble bac­te­r­i­al con­t­a­m­i­na­tion. 

Pred­nisolone Eye Drops are used to treat non-in­fec­tious eye al­ler­gies and in­flam­ma­tion. The man­u­fac­tur­er has is­sued the re­call for 8,000 packs of the prod­uct with the Batch Num­ber N23B27.

Out of an abun­dance of cau­tion, the Min­istry ad­vis­es per­sons who may be in pos­ses­sion of these re­called prod­ucts to dis­con­tin­ue use im­me­di­ate­ly and to re­turn the prod­uct to the place of pur­chase or place re­ceived, where pos­si­ble.

Ad­di­tion­al in­for­ma­tion can be ob­tained by con­tact­ing the Of­fice of the Di­rec­tor of the Chem­istry, Food and Drugs Di­vi­sion via email at cfdd@health.gov.tt or phone at 217-4664 ext. 13101.

The Min­istry of Health will con­tin­ue to mon­i­tor the sit­u­a­tion and ad­vise the pop­u­la­tion as nec­es­sary.